Screening of cytochrome P450 3A4 inhibitors via in silico and in vitro approaches - RSC Advances (RSC Publishing)
![Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research - ScienceDirect Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X19304238-ga1.jpg)
Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research - ScienceDirect
![Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure | American Society of Nephrology Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/early/2019/03/02/CJN.05180418/F2.large.jpg)
Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure | American Society of Nephrology
![References in Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective - The Lancet Oncology References in Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5bf0987b-81a8-4c26-bdf3-6afece0bb772/gr1_lrg.jpg)
References in Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective - The Lancet Oncology
![Table 2 from The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions | Semantic Scholar Table 2 from The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3e764a8aa3ed07fa458b6b76afb0e045320d49ad/3-Table2-1.png)